Envestnet Asset Management Inc. Has $605,000 Stake in Integral Ad Science Holding Corp. $IAS

Envestnet Asset Management Inc. lowered its stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS) by 13.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,857 shares of the company’s stock after selling 11,614 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Integral Ad Science were worth $605,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in IAS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Integral Ad Science by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,326 shares of the company’s stock worth $349,000 after purchasing an additional 1,807 shares in the last quarter. Victory Capital Management Inc. grew its stake in Integral Ad Science by 14.5% during the first quarter. Victory Capital Management Inc. now owns 37,650 shares of the company’s stock worth $303,000 after buying an additional 4,770 shares in the last quarter. Federated Hermes Inc. increased its holdings in Integral Ad Science by 35.0% in the 1st quarter. Federated Hermes Inc. now owns 27,000 shares of the company’s stock valued at $218,000 after buying an additional 7,000 shares during the period. CWM LLC raised its position in shares of Integral Ad Science by 1,248.1% in the 2nd quarter. CWM LLC now owns 9,019 shares of the company’s stock valued at $75,000 after buying an additional 8,350 shares in the last quarter. Finally, Voya Investment Management LLC raised its position in shares of Integral Ad Science by 22.7% in the 1st quarter. Voya Investment Management LLC now owns 47,281 shares of the company’s stock valued at $381,000 after buying an additional 8,761 shares in the last quarter. 95.78% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 12,180 shares of Integral Ad Science stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $10.24, for a total transaction of $124,723.20. Following the transaction, the chief executive officer owned 417,742 shares in the company, valued at approximately $4,277,678.08. The trade was a 2.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Alexis Gil II sold 3,527 shares of the stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $10.18, for a total value of $35,904.86. Following the completion of the sale, the chief accounting officer owned 139,621 shares of the company’s stock, valued at $1,421,341.78. The trade was a 2.46% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 70,131 shares of company stock worth $714,930. 2.00% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on IAS. Robert W. Baird increased their price target on shares of Integral Ad Science from $9.00 to $10.30 and gave the stock a “neutral” rating in a research report on Thursday, September 25th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $10.30 target price (down previously from $14.00) on shares of Integral Ad Science in a report on Thursday, September 25th. Truist Financial lowered Integral Ad Science from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 24th. Wall Street Zen raised Integral Ad Science from a “hold” rating to a “buy” rating in a report on Sunday, August 10th. Finally, BMO Capital Markets set a $10.30 price objective on Integral Ad Science and gave the company a “market perform” rating in a research note on Wednesday, September 24th. Fourteen equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Integral Ad Science currently has a consensus rating of “Hold” and an average target price of $11.52.

Integral Ad Science Price Performance

NASDAQ IAS opened at $10.26 on Tuesday. The company has a market cap of $1.72 billion, a price-to-earnings ratio of 36.64, a price-to-earnings-growth ratio of 1.50 and a beta of 1.59. Integral Ad Science Holding Corp. has a twelve month low of $6.26 and a twelve month high of $11.78. The business’s fifty day moving average is $10.01 and its 200 day moving average is $8.94.

Integral Ad Science (NASDAQ:IAS) last posted its earnings results on Tuesday, November 4th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.02). Integral Ad Science had a net margin of 7.91% and a return on equity of 4.45%. The firm had revenue of $154.36 million during the quarter, compared to the consensus estimate of $149.18 million. On average, research analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.

Integral Ad Science Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.